Patent · US Active

Derivatives of N-hydroxybenzamide for treating HIV infections

US8637702B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Assignee

ITALFARMACO SPA · IT

Inventors

Charles A. Dinarello · Boulder, US
Gianluca FOSSATI · Milano, IT
Paolo Mascagni · Sesto San Giovanni, IT

Key dates

Filing date	Sep 14, 2010
Grant date	Jan 28, 2014
Priority date	—
Expiry date	Sep 14, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compound selected from 4-(2(S)-benzoylamino-3-naphthalen-2-yl-propionylamino)-N-hydroxy-benzamide and benzo[1,3]dioxole-5-carboxylic acid [1(S)-(4-hydroxycarbamoyl-phenylcarbamoyl)-2-naphthalen-2-yl-ethyl]-amide, for use in the treatment of a HIV infection. The compound is administered in combination and/or in temporal proximity with at least one anti-retroviral agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.